Biomarkers and Imaging: Complementary or Subtractive?

Andrea Salzano, Alberto M. Marra, Roberta D'Assante, Michele Arcopinto, Eduardo Bossone, Toru Suzuki, Antonio Cittadini

Research output: Contribution to journalReview articlepeer-review


Heart failure is a life-threatening disease. Its prevalence is characterized by a slow, steady increase, with unacceptable high mortality. Slowing disease progression is imperative. One of the most active field is the development of novel biomarkers. Biomarkers are used in routine clinical care for diagnosis, monitoring (response to treatment), and risk stratification of patients with heart failure. In this review, we consider in 2 different sections: blood-derived and imaging biomarkers. Finally, we analyze the effect of combining these 2 categories of biomarkers available in heart failure, aiming at understanding whether their role is complementary or subtractive.

Original languageEnglish
Pages (from-to)321-331
Number of pages11
JournalHeart Failure Clinics
Issue number2
Publication statusPublished - Apr 2019


  • Biomarkers
  • Cardiovascular disease
  • Heart failure
  • Imaging
  • Prognosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Biomarkers and Imaging: Complementary or Subtractive?'. Together they form a unique fingerprint.

Cite this